The treatment doesn’t replace a vaccine, but it’s a helpful tool in protecting yourself against infection if you’re high-risk for severe COVID-19 outcomes.
Continue reading
Researchers looked at the characteristics and outcomes of COVID-19 breakthrough infections among fully vaccinated people with rheumatic disease, such as rheumatoid arthritis and lupus. They found that, though cases were limited, the outcomes were more severe among this group than in the general population.
Continue reading
A new study found that white patients are more likely to be prescribed stronger doses of opioids than Black patients within the same health care system, which suggests race plays a role in how doctors manage patients’ pain relief.
Continue reading
In many cases, loved ones are well-intentioned but poorly informed. In some scenarios, though, you’re better off distancing yourself from toxic relationships.
Continue reading
There are several factors to be aware of that will affect your risk if you’re around school-aged kids.
Continue reading
The U.S. Food and Drug Administration (FDA) approved a new drug, anifrolumab (Saphnelo), for moderate to severe systemic lupus erythematosus (SLE). This is the first type 1 interferon receptor antagonist for lupus.
Continue reading
Breakthrough infections, in which COVID-19 can develop and spread in vaccinated people, are still considered rare. But people with autoimmune and inflammatory conditions who are immunocompromised have extra concerns when it comes to the risk of COVID-19 and how to stay safe.
Continue reading
Gradually weaning off steroids may lead to less flares among lupus patients in remission than staying on a low-dose treatment, new research found.
Continue reading
New research shows that air purifiers, which filtrate the air in indoor spaces, may add an extra layer of protection against COVID-19.
Continue reading
